167 related articles for article (PubMed ID: 6390198)
21. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
22. Effect of treatment on the evolution of renal abnormalities in lupus nephritis.
Balow JE; Austin HA; Muenz LR; Joyce KM; Antonovych TT; Klippel JH; Steinberg AD; Plotz PH; Decker JL
N Engl J Med; 1984 Aug; 311(8):491-5. PubMed ID: 6749206
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressive therapy in systemic lupus erythematosus.
Russell AS; Bretscher PA
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():194-8. PubMed ID: 3302253
[TBL] [Abstract][Full Text] [Related]
24. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
25. Cyclophosphamide or azathioprine in lupus glomerulonephritis. A controlled trial: results at 28 months.
Decker JL; Klippel JH; Plotz PH; Steinberg AD
Ann Intern Med; 1975 Nov; 83(5):606-15. PubMed ID: 1106278
[TBL] [Abstract][Full Text] [Related]
26. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
[TBL] [Abstract][Full Text] [Related]
27. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
28. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
29. [Treatment with immunosuppressive agents in disseminated lupus erythematosus and in some evolutive nephropathies].
Purice S; Ghelerter L; Matei I; Brunazian G
Stud Cercet Med Interna; 1969; 10(2):147-53. PubMed ID: 5344004
[No Abstract] [Full Text] [Related]
30. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
Branten AJ; Wetzels JF
Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
[TBL] [Abstract][Full Text] [Related]
31. Treatment of lupus nephritis.
Pollak VE
Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
[No Abstract] [Full Text] [Related]
32. Immunosuppressive treatment of Berger's disease.
Faedda R; Pirisi M; Satta A; Bosincu L; Bartoli E
Clin Pharmacol Ther; 1996 Nov; 60(5):561-7. PubMed ID: 8941029
[TBL] [Abstract][Full Text] [Related]
33. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
[TBL] [Abstract][Full Text] [Related]
34. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group.
Lewis EJ; Hunsicker LG; Lan SP; Rohde RD; Lachin JM
N Engl J Med; 1992 May; 326(21):1373-9. PubMed ID: 1569973
[TBL] [Abstract][Full Text] [Related]
35. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
Ferrari P; Frey FJ
Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
[TBL] [Abstract][Full Text] [Related]
36. Alternative modes of cyclophosphamide and azathioprine therapy in lupus nephritis.
Dinant HJ; Decker JL; Klippel JH; Balow JE; Plotz PH; Steinberg AD
Ann Intern Med; 1982 Jun; 96(6 Pt 1):728-36. PubMed ID: 7046543
[TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive agents in lupus nephritis: a critical analysis.
Wagner L
Medicine (Baltimore); 1976 May; 55(3):239-50. PubMed ID: 775253
[No Abstract] [Full Text] [Related]
38. Progressive lupus glomerulonephritis. Treatment with prednisone and combined prednisone and cyclophosphamide.
Donadio JV; Holley KE; Ferguson RH; Ilstrup DM
Mayo Clin Proc; 1976 Aug; 51(8):484-94. PubMed ID: 950801
[TBL] [Abstract][Full Text] [Related]
39. Prednisone and azathioprine compared to prednisone plus low-dose azathioprine and cyclophosphamide in the treatment of diffuse lupus nephritis.
Ginzler E; Diamond H; Guttadauria M; Kaplan D
Arthritis Rheum; 1976; 19(4):693-9. PubMed ID: 782464
[TBL] [Abstract][Full Text] [Related]
40. The natural history and response to therapy of lupus nephritis.
Ginzler EM; Bollet AJ; Friedman EA
Annu Rev Med; 1980; 31():463-87. PubMed ID: 6994624
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
